AHSG and metabolic disease: Based on its role in metabolic processes, numerous pharmacological intervention studies for Fetuin-A have been examined in the metabolic disease model and it was found that liraglutide and pioglitazone reduce the circulating levels of Fetuin-A, while salsalate decreases Fetuin-A mRNA levels [115,168,169,170].